Diaceutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Diaceutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $23,699,000. Profit margin reached -7%. Total operating expenses were $22,724,000.

Profit Margin

Diaceutics PLC (LSE:DXRX.L): Profit margin
2015 1.39M -103.48K -7.4%
2016 4.58M 747.13K 16.28%
2017 7.37M 663.19K 9%
2018 10.37M 632.30K 6.1%
2019 13.44M 398K 2.96%
2020 12.69M 263K 2.07%
2021 13.94M 561K 4.02%
2022 19.50M 724K 3.71%
2023 23.69M -1.74M -7.37%

DXRX.L Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
23.69M19.50M13.94M12.69M13.44M10.37M7.37M4.58M1.39M
Cost of revenue
3.99M5.46M3.37M3.36M3.13M3.57M2.48M1.93M952.65K
Gross profit
19.70M14.03M10.56M9.33M10.31M6.80M4.88M2.65M444.92K
Operating exp.
Research and development
000078K0486.94K838.10K455.21K
Selling and marketing
0-2.57M-1.62M-73K-197.98K0000
Total operating expenses
22.72M13.70M10.25M9.94M8.19M5.62M3.98M1.77M508.30K
Operating income
-2.71M331K313K-610K2.12M1.40M901.24K882.28K-63.38K
Other income (expenses), net
280K147K-20K-72K-1.78M-528.66K-116.38K-97.31K-40.10K
Income before tax
-2.43M478K293K-929K340.32K877.26K784.85K784.97K-103.48K
Income tax expense
-692K-246K-268K-1.19M-57.55K244.95K121.66K37.83K0
Net income
-1.74M724K561K263K398K632.30K663.19K747.13K-103.48K
Earnings per share
Basic EPS
-0.020.000.000.000.000.010.000.01-3.84
Diluted EPS
-0.020.000.000.000.000.010.000.01-3.84
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source